Sana Biotechnology, Inc. (NASDAQ:SANA) Receives Average Recommendation of “Moderate Buy” from Analysts
Shares of Sana Biotechnology, Inc. (NASDAQ:SANA – Get Free Report) have been given an average recommendation of “Moderate Buy” by the seven brokerages that are currently covering the company, Marketbeat reports. One investment analyst has rated the stock with a hold rating and six have assigned a buy rating to the company. The average 12 […]
Shares of Sana Biotechnology, Inc. (NASDAQ:SANA – Get Free Report) have been given an average recommendation of “Moderate Buy” by the seven brokerages that are currently covering the company, Marketbeat reports. One investment analyst has rated the stock with a hold rating and six have assigned a buy rating to the company. The average 12 […]
